Global levels of specific histone modifications and an epigenetic gene signature predict prostate cancer progression and development T Bianco-Miotto, K Chiam, G Buchanan, S Jindal, TK Day, M Thomas, ... Cancer epidemiology, biomarkers & prévention 19 (10), 2611-2622, 2010 | 192 | 2010 |
Circulating serum exosomal miRNAs as potential biomarkers for esophageal adenocarcinoma K Chiam, T Wang, DI Watson, GC Mayne, TS Irvine, T Bright, L Smith, ... Journal of gastrointestinal surgery 19 (7), 1208-1215, 2015 | 149 | 2015 |
Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer HM Lin, L Castillo, KL Mahon, K Chiam, BY Lee, Q Nguyen, MJ Boyer, ... British journal of cancer 110 (10), 2462-2471, 2014 | 147 | 2014 |
Epigenetic biomarkers in prostate cancer: Current and future uses K Chiam, C Ricciardelli, T Bianco-Miotto Cancer letters 342 (2), 248-256, 2014 | 102 | 2014 |
Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer KL Mahon, HM Lin, L Castillo, BY Lee, M Lee-Ng, MD Chatfield, K Chiam, ... British journal of cancer 112 (8), 1340-1348, 2015 | 71 | 2015 |
GSTP1 DNA methylation and expression status is indicative of 5-aza-2′-deoxycytidine efficacy in human prostate cancer cells K Chiam, MM Centenera, LM Butler, WD Tilley, T Bianco-Miotto PloS one 6 (9), e25634, 2011 | 62 | 2011 |
INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival NK Rynkiewicz, CG Fedele, K Chiam, R Gupta, JG Kench, LM Ooms, ... The Prostate 75 (1), 92-102, 2015 | 38 | 2015 |
The dynamic and static modification of the epigenome by hormones: a role in the developmental origin of hormone related cancers K Chiam, WD Tilley, LM Butler, T Bianco-Miotto Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1795 (2), 104-109, 2009 | 31 | 2009 |
Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific death SE Birch, JG Kench, E Takano, P Chan, AL Chan, K Chiam, AS Veillard, ... Annals of oncology 25 (12), 2392-2397, 2014 | 30 | 2014 |
Serum outperforms plasma in small extracellular vesicle microRNA biomarker studies of adenocarcinoma of the esophagus K Chiam, GC Mayne, T Wang, DI Watson, TS Irvine, T Bright, LT Smith, ... World journal of gastroenterology 26 (20), 2570, 2020 | 20 | 2020 |
Identification of microRNA biomarkers of response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma using next generation sequencing K Chiam, GC Mayne, DI Watson, RJ Woodman, TF Bright, MZ Michael, ... Annals of Surgical Oncology 25, 2731-2738, 2018 | 19 | 2018 |
An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy AY Zhang, K Chiam, Y Haupt, S Fox, S Birch, W Tilley, LM Butler, ... International journal of cancer 144 (5), 1151-1159, 2019 | 18 | 2019 |
Characterization of the prostate cancer susceptibility gene KLF6 in human and mouse prostate cancers K Chiam, NK Ryan, C Ricciardelli, TK Day, G Buchanan, AM Ochnik, ... The Prostate 73 (2), 182-193, 2013 | 18 | 2013 |
Use of multiparametric magnetic resonance imaging (mpMRI) in active surveillance for low-risk prostate cancer: a scoping review on the benefits and harm of mpMRI in different … K Chiam, C Carle, S Hughes, JG Kench, HH Woo, S Lord, DP Smith Prostate Cancer and Prostatic Diseases 24 (3), 662-673, 2021 | 11 | 2021 |
Mutant p53 mediates sensitivity to cancer treatment agents in oesophageal adenocarcinoma associated with MicroRNA and SLC7A11 expression AK Eichelmann, GC Mayne, K Chiam, SL Due, I Bastian, F Butz, T Wang, ... International journal of molecular sciences 22 (11), 5547, 2021 | 9 | 2021 |
MicroRNA profiling in oesophageal adenocarcinoma cell lines and patient serum samples reveals a role for miR-451a in radiation resistance F Butz, AK Eichelmann, GC Mayne, T Wang, I Bastian, K Chiam, S Marri, ... International Journal of Molecular Sciences 21 (23), 8898, 2020 | 9 | 2020 |
Family history, obesity, urological factors and diabetic medications and their associations with risk of prostate cancer diagnosis in a large prospective study V Nair-Shalliker, A Bang, S Egger, XQ Yu, K Chiam, J Steinberg, MI Patel, ... British Journal of Cancer 127 (4), 735-746, 2022 | 4 | 2022 |
Characteristics associated with the use of diagnostic prostate biopsy and biopsy outcomes in Australian men K Chiam, A Bang, MI Patel, V Nair-Shalliker, DL O’Connell, DP Smith Cancer Epidemiology, Biomarkers & Prevention 30 (9), 1735-1743, 2021 | 2 | 2021 |
Benefits and harms of prostate specific antigen testing according to Australian guidelines M Caruana, R Gulati, R Etzioni, A Barratt, BK Armstrong, K Chiam, ... International Journal of Cancer 154 (4), 648-658, 2024 | 1 | 2024 |
The complex impact of COVID-19 on cancer outcomes in Australia K Canfell, K Chiam, C Nickson, GB Mann Med J Aust 219 (9), 402-404, 2023 | 1 | 2023 |